Replies to post #89558 on Anavex Life Sciences Corp (AVXL)

[Graniteguy]

Far too low a price.

[powerwalker]

Ionis has a strong relationship with Biogen, so Anavex has to prove 2-73 is better than whatever Ionis and Biogen are working on:

http://www.prnewswire.com/news-releases/ionis-earns-5-million-milestone-payment-from-biogen-for-advancing-a-new-program-under-its-broad-neurology-strategic-collaboration-300400952.html?utm_medium=nl&utm_source=internal&mrkid=4508591&mkt_tok=eyJpIjoiTXpJd056VTVORGMzTXpaaCIsInQiOiJvbk1zNmlhRlFsNW0ya0xmRDU0XC9KZUF3THc0QXFMWUJ4dlkxS2pTMElLWFNjNXZyd2R4QXZHK3h4dHZjQnlZOXJ4bzhcL1RrV0ZMcmxpU1lGOVZSdERlYXZjdXM0ZThQTWVkTU9CWXptc1wvNWtVXC9seGNHOFYyVXJEdlZJZ3hidEgifQ%3D%3D

BTW - How do come up with your moniker? Dropping the last "t" and you have my nickname in college ... something to do with my approach on the b-ball court and f-ball field.

[Bourbon_on_my_cornflakes]

$3 billion would be the theft of a lifetime, if, as you premise, that the MS study proves fruitful. Everybody knows that MS, big as it is, is only a runner up to the value of a viable alz treatment. The price for that STARTS at $10 billion based on hard market data.

There will be no acquisition until the market prices in a working alz treatment and Rett treatment...which could be here in less than a year. When we are over $100 share, then they can offer a 100% premium and get to a proper price

[nobrainerstocks]

You mean 3 billion for MS alone right?

[Whiskey/Sausage]

$5B on the low end. A year from now with conclusion of the the P2 & P3's, and they'll be looking at a $20B buyout minimum.